BOBBIE ADAMS: Open Payments
NPI 1396958245 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 23 payments from 11 companies in 2025. Trend: 2023 $637 · 2024 $698 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 8 | $217 |
| ABBVIE INC. | 4 | $66 |
| MDD US Operations, LLC | 2 | $31 |
| Lundbeck LLC | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Indivior Inc. | 1 | $19 |
| LivaNova USA, Inc. | 1 | $18 |
Products named: FYCOMPA, QULIPTA, Gocovri, VYEPTI, AJOVY, Symbravo, SPRAVATO, AMYVID.
Industry payments across KY — which companies pay providers there.
